February 6, 2025 BHR Newsletter 1. Hospital group urges White House to grant tariff exceptions Full story 2. States attempt to protect 340B with new bills: 7 notes Full story 3. Pennsylvania system opens 1st on-site pharmacy Full story 4.…
Pharmacy Report
February 5, 2025 BHR Newsletter 1. Tariffs on China threaten to drive up drug costs, exacerbate shortages: 5 notes Full story 2. GLP-1 drug fails to slow Parkinson's: Study Full story 3. Keytruda's looming patent expiry raises concerns Full story…
February 4, 2025 BHR Newsletter 1. Merck's 2025 outlook falls after pausing vaccine shipments to China Full story 2. Landmark criminal case challenges telemedicine abortion shield laws Full story 3. Top 15 pharmacy schools by NAPLEX pass rates Full story 4.…
February 3, 2025 BHR Newsletter 1. Behind Intermountain Health's in-house PBM Full story 2. All lines restarted at Baxter plant damaged in storm: 3 notes Full story 3. Drugmakers increase prices on 800 medications: 5 things to know Full story…
January 30, 2025 BHR Newsletter 1. Pharmacy subscription model boosts adherence, reduces costs: Study Full story 2. FDA warns GLP-1 compounder over safety rules Full story 3. Intermountain's on-demand pharmacy: 5 details Full story 4. Better patient care with real-time…
Advertisement
January 29, 2025 BHR Newsletter 1. Protecting the 340B program: A vital step toward a healthier nation Full story 2. Medicaid 'outage' raises questions: The latest Full story 3. Vizient: Expect 3.84% increase in hospital pharmacy spend Full story 4.…
January 28, 2025 BHR Newsletter 1. GLP-1s are reshaping cardiovascular care: Cedars-Sinai Full story 2. 9 drugs in shortage Full story 3. Duke Health, UNC Health to build North Carolina's 1st standalone children's hospital Full story 4. Better patient care…
January 27, 2025 BHR Newsletter 1. More health systems bringing PBMs in house: 5 things to know Full story 2. The No. 1 change pharmacy execs are driving in 2025 Full story 3. PBMs hit with $10 million verdict in…
January 23, 2025 BHR Newsletter 1. Guthrie appoints 1st chief pharmacy officer from Ascension Full story 2. Baxter boosts allocations to 100% for 2 IV solutions: 3 notes Full story 3. FDA issues warning on anaphylaxis risk with MS drugs…
January 22, 2025 BHR Newsletter 1. FDA approves 1st monotherapy drug for treatment-resistant depression Full story 2. Novartis sues HHS over 340B pricing model Full story 3. GLP-1s linked to wide range of health benefits: Study Full story 4. Pharmacy leaders…